Product Information
CLONAZEPAM 1 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.0250 per EA under NDC 43547040710. Its NADAC has been published 426 times since May 2, 2018.
Strength
1 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547040710
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA077856On Market Since
2/15/2018
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 1 MG TABLET has been published 426 times since May 2, 2018, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0250 per EA |
|---|---|
| All-time high | $0.0348 (Apr 15, 2020) |
| All-time low | $0.0246 (Jul 18, 2018) |
| 52-week high | $0.0302 |
| 52-week low | $0.0248 |
| Median price | $0.0303 |
| Average price | $0.0300 |
| Largest weekly change | +23.6% (Jun 19, 2024) |
| Weeks tracked | 426 |
| Tracking since | May 2, 2018 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLONAZEPAM 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 1 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.0250 per EA (NDC 43547040710), effective Jun 24, 2026.
How has the price of CLONAZEPAM 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 1 MG TABLET has held within roughly two percent of its current level. It has been tracked across 426 weekly CMS publications since May 2, 2018.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 1 MG TABLET?
Since May 2, 2018, the NADAC for CLONAZEPAM 1 MG TABLET has ranged from a low of $0.0246 (Jul 18, 2018) to a high of $0.0348 (Apr 15, 2020), with a median of $0.0303 per EA.
Are there cheaper alternatives to CLONAZEPAM 1 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as CLONAZEPAM 1 MG TABLET, but none are currently priced below it.
Who manufactures CLONAZEPAM 1 MG TABLET?
CLONAZEPAM 1 MG TABLET (NDC 43547040710) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification